Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP643403.RAfR8AnUnT5uc-Un9glnzFQ0EdEg8PydGfP4G0RvuTtWg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP643403.RAfR8AnUnT5uc-Un9glnzFQ0EdEg8PydGfP4G0RvuTtWg130_assertion type Assertion NP643403.RAfR8AnUnT5uc-Un9glnzFQ0EdEg8PydGfP4G0RvuTtWg130_head.
- NP643403.RAfR8AnUnT5uc-Un9glnzFQ0EdEg8PydGfP4G0RvuTtWg130_assertion wasGeneratedBy ECO_0000203 NP643403.RAfR8AnUnT5uc-Un9glnzFQ0EdEg8PydGfP4G0RvuTtWg130_provenance.
- NP643403.RAfR8AnUnT5uc-Un9glnzFQ0EdEg8PydGfP4G0RvuTtWg130_assertion wasDerivedFrom befree-20140225 NP643403.RAfR8AnUnT5uc-Un9glnzFQ0EdEg8PydGfP4G0RvuTtWg130_provenance.
- NP643403.RAfR8AnUnT5uc-Un9glnzFQ0EdEg8PydGfP4G0RvuTtWg130_assertion SIO_000772 10389944 NP643403.RAfR8AnUnT5uc-Un9glnzFQ0EdEg8PydGfP4G0RvuTtWg130_provenance.
- NP643403.RAfR8AnUnT5uc-Un9glnzFQ0EdEg8PydGfP4G0RvuTtWg130_assertion evidence source_evidence_literature NP643403.RAfR8AnUnT5uc-Un9glnzFQ0EdEg8PydGfP4G0RvuTtWg130_provenance.
- NP643403.RAfR8AnUnT5uc-Un9glnzFQ0EdEg8PydGfP4G0RvuTtWg130_assertion description "[We have developed a novel nonviral interleukin 2 (IL-2) gene therapy that demonstrates significant treatment-specific, antitumor efficacy in combination with subtotal surgical resection in a head and neck cancer murine model.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP643403.RAfR8AnUnT5uc-Un9glnzFQ0EdEg8PydGfP4G0RvuTtWg130_provenance.